HQD: The Leading E-Cigarette Brand in Russia

Business by 2FIRSTS.ai
Jun.20.2023
HQD: The Leading E-Cigarette Brand in Russia
2FIRSTS reports on HQD's success as a leading e-cigarette brand in Russia, despite recent industry struggles and new regulations.

On June 17th and 18th, the Vape Club Show Moscow e-cigarette exhibition took place at the Crocus Expo Convention Center in Moscow. As the official media partner of the event, 2FIRSTS provided on-site coverage of the exhibition.

 

At the exhibition, 2FIRSTS interviewed a representative of HQD, a Russian distributor for the e-cigarette brand. He shared with 2FIRSTS the reasons why HQD is leading the e-cigarette market in Russia and his outlook for the future.

 

In 2019, the e-cigarette industry faced a downturn with people doubting its future prospects. Sales decreased and the path to market recovery seemed uncertain. However, during this critical time, HQD saw the potential in a new disposable device based on nicotine salt, becoming one of the first brands to promote this category of product in Russia.

 

The distributors of HQD have consistently received support from professional retailers by offering the best commercial terms, high-quality service, and superior product quality in the market. As a result, all e-cigarettes in Russia are now colloquially referred to as "Ashka" or "Ashkudishka" (both of which are phonetic translations of HQD in Russian), similar to how all printers are called "Xerox.

 

He summarized the three key factors that contributed to HQD's success in the Russian market.

 

First and foremost, collaborate with reliable partners. Secondly, provide high-quality product standards. Lastly, formulate strategic and effective marketing plans after careful consideration.

 

He holds an open attitude towards a series of e-cigarette control bills recently introduced in Russia.

 

He believes that when it comes to restrictions on certain ingredients in e-liquid, communication and negotiation should be held with industry representatives and associations. Only by fully understanding the market situation can positive decisions be made that benefit the market changes. These bills and upcoming lists of substance ingredients will have a significant regulatory impact on the market, so it is important to involve as many stakeholders as possible in the decision-making process.

 

He himself holds an optimistic view on the development of the e-cigarette market in Russia. He believes that within the next 10 years, up to 30% of traditional cigarette smokers will switch to smoke-free products, thus greatly reducing the mortality rate caused by traditional tobacco consumption.

 

Furthermore, extensive research, including studies conducted by medical experts, has demonstrated the benefits of many other vaporized products such as e-cigarettes, particularly in terms of their lower health risks. Therefore, whether decision-makers have taken these factors into sufficient consideration will have a significant impact on the development of the market.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Reemtsma says German illegal e-cigarette seizures reached 70% of 2025 total, pouches 179%
Reemtsma says German illegal e-cigarette seizures reached 70% of 2025 total, pouches 179%
Reemtsma said its first-half 2026 black-market tracker for tobacco and nicotine products showed a continued rise in officially reported seizures in Germany, with illegal e-cigarette seizures reaching 70% of the full-year 2025 level and snus and nicotine pouch seizures reaching 179% of last year’s total.
Jul.08
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13